News

In addition, Catholic Healthcare West (CHW) has received Institutional Review Board approval for the clinical trial, which is expected to begin soon. Advanced Cell Technology’s (ACT) myoblast program

Under the terms of the agreement, AVI will issue up to $7.5 million in AVI common stock valued at $1.3161 per share in exchange for all outstanding shares

Under the terms of the agreement, M’s Science will grant Eisai the following rights in exchange for a certain payment: the first review right for evaluating the results

The penicillin sterile facility in Bangalore manufactures sterile injectables in dry powder vials. The plant supports important current and future submissions for the US market. The facility was

Through the study of the physiology of sperm motility, more specifically of ‘rapid swimmers’ that cause fertilization, Spermatech has identified biological targets that could be exploited in the

The study focuses on a new procedure, called airway bypass, that involves creating pathways in the lung for trapped air (one of the primary causes of shortness breath)

The new collaboration positions VistaGen to continue to leverage the embryonic stem (ES) cell biology expertise and ES cell technologies of Dr Gordon Keller, director of the McEwen

Under the terms of this agreement, Wuhan Institute of Biological Products (WIBP) gains exclusive access to ProMetic’s Plasma Protein Purification System for the Chinese market. Upon successfully implementing

Germany acted as reference member state and the 28 concerned member states decided to recognize the approval granted in 2006 by the German medicines agency (BfArM) of this